Ask AI
ProCE Banner Activity

Amplifying the Academic/Community Connection for Optimizing Asparaginase Therapy in ALL

Clinical Thought

Expert highlights and takeaways from an educational program on amplifying the academic and community connection for optimizing asparaginase therapy in the care of patients with acute lymphocytic leukemia (ALL).

Released: January 13, 2026

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by an educational grant from Jazz Pharmaceuticals, Inc.

Jazz Pharmaceuticals, Inc.

Faculty Disclosure

Primary Author

Amir T. Fathi, MD: consultant/advisor/speaker: AbbVie, Astellas, AstraZeneca, Autolus, Bristol Myers Squibb, Daiichi Sankyo, Genmab, Genentech, Johnson & Johnson, Kura, Novartis, Prelude, Schrödinger, Servier, Takeda, ThermoFisher; researcher (paid to institution): AbbVie, Bristol Myers Squibb, Genentech, Kura, Servier.